In our study, when we evaluated OMs separately, exenatide and phentermine/topiramate showed a trend towards reduction in MACE compared to UC; however, this was not statistically significant, and the sample size was small (Table 3 ).
← all excerpts
Major Adverse Cardiovascular Event Outcomes in Patients With Obesity and Type 2 Diabetes Undergoing Medical Weight Management.
1
—
—